Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Pharmacology|November 20, 2018
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety DatabaseReo Tanoshima, Amna Khan, Agnieszka K Biala, et al.
Pediatric Nephrology (Berlin, Germany)|June 24, 2022
Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countriesZulfan Zazuli, Catharina J P Op 't Hoog, Susanne J H Vijverberg, et al.
Pediatric Blood & Cancer|March 22, 2025
Amino Acid Stress Response Genes Contribute to a 25-Fold Increased Risk of L-Asparaginase-Induced HypersensitivitySpencer J Anderson, Erika N Scott, Edward J Raack, et al.
Cancer|September 7, 2021
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessmentsAnnelot J M Meijer, Kathy H Li, Beth Brooks, et al.
The Lancet. Child & Adolescent Health|February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort studyDiana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Therapeutic Drug Monitoring|July 12, 2011
CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot studySondra VanderVaart, Howard Berger, Johanna Sistonen, et al.
NPJ Genomic Medicine|May 22, 2021
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicityErika N Scott, Galen E B Wright, Britt I Drögemöller, et al.
Clinical Pharmacokinetics|March 17, 2015
A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral DoseNieves Velez de Mendizabal, Ricardo Jimenez-Mendez, Erin Cooke, et al.
British Journal of Clinical Pharmacology|May 20, 2016
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicityFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Pharmacology|November 20, 2018
Analyses of Adverse Drug Reactions-Nationwide Active Surveillance Network: Canadian Pharmacogenomics Network for Drug Safety DatabaseReo Tanoshima, Amna Khan, Agnieszka K Biala, et al.
Pediatric Nephrology (Berlin, Germany)|June 24, 2022
Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countriesZulfan Zazuli, Catharina J P Op 't Hoog, Susanne J H Vijverberg, et al.
Pediatric Blood & Cancer|March 22, 2025
Amino Acid Stress Response Genes Contribute to a 25-Fold Increased Risk of L-Asparaginase-Induced HypersensitivitySpencer J Anderson, Erika N Scott, Edward J Raack, et al.
Cancer|September 7, 2021
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessmentsAnnelot J M Meijer, Kathy H Li, Beth Brooks, et al.
The Lancet. Child & Adolescent Health|February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort studyDiana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Therapeutic Drug Monitoring|July 12, 2011
CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot studySondra VanderVaart, Howard Berger, Johanna Sistonen, et al.
NPJ Genomic Medicine|May 22, 2021
Transcriptome-wide association study uncovers the role of essential genes in anthracycline-induced cardiotoxicityErika N Scott, Galen E B Wright, Britt I Drögemöller, et al.
Clinical Pharmacokinetics|March 17, 2015
A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral DoseNieves Velez de Mendizabal, Ricardo Jimenez-Mendez, Erin Cooke, et al.
British Journal of Clinical Pharmacology|May 20, 2016
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicityFolefac Aminkeng, Colin J D Ross, Shahrad R Rassekh, et al.
Circulation|December 7, 2021
Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced CardiotoxicityTarek Magdy, Mariam Jouni, Hui-Hsuan Kuo, et al.
Pageof 14